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AT A GLANCE SUMMARY 
P. aeruginosa infection of the lungs induces neutrophil recruitment, platelet recruitment 
and release of platelet derived pro-inflammatory mediators. Mice experimentally depleted 
of platelets infected with P. aeruginosa demonstrate decreased neutrophil recruitment 
combined with increased total bacterial load and increased mortality rates. 
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ABSTRACT 
Platelets have been implicated in pulmonary inflammatory cell recruitment following 
exposure to allergic and non-allergic stimuli, but little is known about the role of platelets in 
response to pulmonary infection with Pseudomonas aeruginosa (P. aeruginosa). In this 
study, we have investigated the impact of the experimental depletion of circulating platelets 
on a range of inflammatory and bacterial parameters, and their subsequent impact on 
mortality in a murine model of pulmonary infection with P. aeruginosa. P. aeruginosa 
infection in mice induced a mild but significant state of peripheral thrombocytopenia in 
addition to pulmonary platelet accumulation. Increased platelet activation was detected in 
infected mice through increased levels of the platelet derived mediators PF-4 and β-TG in 
bronchoalveolar lavage fluid (BALF) and blood plasma. In mice depleted of circulating 
platelets, pulmonary neutrophil recruitment was significantly reduced 24 hours’ post 
infection, whilst the incidence of systemic dissemination of bacteria was significantly 
increased compared to non-platelet depleted control mice. Furthermore, mortality rates 
were increased in bacterial infected mice depleted of circulating platelets. This work 
demonstrates a role for platelets in the host response towards a gram-negative bacterial 
respiratory infection. 
Word Count: 184 
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INTRODUCTION 
P. aeruginosa is a gram negative, opportunistic bacterium, recognised as one of the major 
colonising species in the lungs of cystic fibrosis (CF) patients with chronic bacterial 
infections, hospitalised cancer patients and in infections associated with severe burns [1–3]. 
The importance of platelets in both the innate and adaptive inflammatory responses has 
been highlighted through the release of numerous preformed mediators from internal alpha 
(α) and dense granules. These mediators contribute to the inflammatory response through 
processes such as cell adhesion and migration, whilst also contributing to wound repair [4]. 
Indeed, several animal models of inflammation have described a critical role for platelets in 
inflammatory cell recruitment. These include eosinophil and lymphocyte recruitment in 
allergic inflammation, and neutrophil recruitment in models of acute lung injury (ALI), 
rheumatoid arthritis (RA) and cardiovascular diseases (CVD) [5–8]. Furthermore, pulmonary 
platelet accumulation has been observed in models of allergic inflammation and ALI 
following allergic and non-allergic insults respectively [9,10]. 
Evidence of platelet activation in infectious diseases has been well documented, with 
increases in the expression of platelet activation markers in patients admitted to hospital 
with numerous infectious diseases. These markers include increases in the incidence of 
platelet-monocyte and platelet-neutrophil complexes in the circulation, increased levels of 
surface P-selectin expression and increased granular secretion [2]. A number of patients 
with sepsis also present to the clinic with thrombocytopenia, which has been associated 
with a worse prognosis and increased mortality when compared to patients presenting with 
normal platelet levels. This further highlights a role for platelets in this condition [11–13].  
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Platelet activation associated with bacterial infections has been reproduced in several 
animal models of pulmonary bacterial infections including Staphylococcus aureus and 
Klebsiella pneumoniae induced sepsis [14,15]. In these models thrombocytopenia has been 
associated with enhanced pulmonary bacterial load and increased systemic infection 
[15,16]. Direct interactions between platelets and numerous bacterial pathogens, including 
S. aureus, Helicobacter Pylori and P. aeruginosa, have been reported both in vitro and in vivo 
[17]. These interactions have been associated with increased pulmonary platelet 
accumulation and reversible platelet adhesion [17], whilst bacterial derived toxins have also 
been reported to modulate platelet function [18]. Other research has reported that direct 
interactions between platelets and microorganisms leads to subsequent phagocytosis of S. 
aureus, S. pneumonaie and P. aeruginosa by platelets, as an additional method of removing 
the bacteria from the infected tissue [14]. Furthermore, it has been suggested that platelets 
also possess the capacity to augment the antimicrobial effects of other immune cells 
[19,20].  
Clearly, in addition to their involvement in hemostatic and inflammatory processes, there 
are several mechanisms by which platelets may contribute towards host defence in 
response to invading pathogens. The aim of this study was to investigate the role of 
platelets in pulmonary infection with P. aeruginosa by studying the effect of platelet 
depletion on bacterial induced leukocyte recruitment, bacterial growth and the systemic 
dissemination of bacteria. We utilised a well-established murine model of chronic lung 
infection induced by the P. aeruginosa strain RP73. This strain has been previously reported 
to show histopathological lesions akin to those observed in CF patients with chronic 
infections [21,22],  thus making this a clinically relevant strain to investigate in the context 
of chronic lung infections. 
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METHODS 
Further details of methodology present within the supplemental section. 
Infection with P. aeruginosa embedded in agar beads and induction of platelet depletion 
in mice 
All animal studies were carried out under appropriate UK and Italian legislation.  Male 
C57/Bl6 mice were anaesthetised and inoculated with P. aeruginosa strain RP73 embedded 
agar beads at either 1x10
6
 or 1x10
5
 cfu/mouse using the method previously described by 
Bragonzi and colleagues [21]. Sham control mice were inoculated with sterile agar beads. 24 
hours before infection, mice were treated intra-muscularly (i.m) with anti-GPIbα platelet 
depleting or IgG control antibodies. Platelet numbers were enumerated in whole blood 
using an improved Neubauer haemocytometer to ensure sufficient platelet depletion. 
 
Quantification of the platelet activation markers Platelet-Factor 4 (PF-4) and β-
thromboglobulin (β-TG) via ELISA 
24 hours post infection, plasma was isolated from citrated blood and BALF collected. Total 
levels of platelet derived PF-4 and β-TG were quantified from all samples and measured by 
ELISA according to manufacturer’s protocols. 
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Bronchoalveolar lavage collection and analysis  
24 hours post infection, BALF was collected. Cells were stained with Turk’s nuclear stain and 
enumerated under a x20 objective using an Improved Neubauer haemocytometer. Cytospin 
slides were stained using Diff-Quick for differential cell count quantification. 
 
Lung, spleen and kidney harvest for microbiological and histological analysis  
24 hours post infection, colony forming units (CFUs) were quantified in lung, spleen and 
kidney homogenates. Lungs from separate mice were fixed in 10% formalin and embedded 
in paraffin blocks for histological analysis. Tissue sections were immunostained for platelets 
using a platelet specific anti-CD42b antibody, whilst additional sections were stained with an 
anti-neutrophil elastase antibody or with Haematoxylin and Eosin for visualisation of 
inflammatory cell infiltrate. 
 
Platelet quantification in BAL fluid 
Cytospins prepared from BAL fluid were immunostained for platelets using a platelet 
specific anti-CD41 antibody, a secondary mouse-adsorbed biotinylated anti-rat secondary 
antibody, and an avidin-biotin-HRP complex. Stained platelets were quantified by traversing 
the whole area of the cytospin under an x40 objective. 
 
Evaluation of biochemical markers of metabolic acidosis 
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24 hours post infection with 1x10
5
 cfu/mouse P. aeruginosa, blood was collected via cardiac 
puncture into heparin coated syringes. Blood biochemical changes were measured using a 
handheld i-STAT blood analyser and EC8+ cartridges. 
 
Platelet-Bacterial Co-cultures. 
Primary overnight cultures of P. aeruginosa (RP73) were prepared and diluted to 1x10
6
 
cfu/ml. Washed platelets were isolated from citrated blood from healthy male C57/Bl6 mice 
and diluted to 1x10
6
 platelets/ml. P. aeruginosa and platelets were incubated together at a 
1:1 ratio and cultured at 37°C. Aliquots of the co-culture were taken periodically over 8 
hours and plated for cfu quantification. 
 
Statistical Analysis 
Data from bacterial studies are expressed as mean ± SEMs. Data were tested for normality 
using the Shapiro-Wilk normality test and analysed using a 1-way ANOVA, followed by 
Bonferroni’s multiple comparison test. Weight data was analysed using a Kruskal-Wallis test 
followed Dunn’s multiple comparison test. ELISA data was analysed using a Two-Tailed 
Mann Whitney T-test. Survival curves were analysed using a Mantel-Cox test. A P value of 
less than 0.05 was considered significant.  
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RESULTS 
Circulating platelet numbers were suppressed following P. aeruginosa infection 
A significant decrease in circulating platelet numbers was observed 24 hours post infection 
with P. aeruginosa. This was significant in mice infected with both 1x10
6
 cfu/mouse P. 
aeruginosa (Sham: 6.8 ± 0.4x10
8 
platelets/ml vs. P. aeruginosa: 5.9 ± 0.5x10
8
 platelets/ml, 
13% decrease, P<0.05, Figure 1A) and 1x10
5
 cfu/mouse P. aeruginosa (Sham: 6.7 ± 0.4x10
8 
platelets/ml vs. P. aeruginosa: 5.6 ± 0.3x10
8
 platelets/ml, 17% decrease, P<0.05, Figure 1B). 
The occurrence of peripheral thrombocytopaenia after lung infection may be a consequence 
of localised pulmonary platelet recruitment due to platelet activation. We therefore 
investigated whether platelet activation and accumulation had occurred in the lungs 24 
hours post infection. 
 
Pulmonary P. aeruginosa infection caused an increase in platelet-associated activation 
markers 
Upon platelet activation, PF-4 and β-TG are secreted from internal granules. We therefore 
measured the levels of β-TG and PF-4 secretion as indicators of platelet activation in blood 
plasma and BALF. 24 hours post infection with P. aeruginosa, a significant increase in plasma 
β-TG levels was observed when compared to sham controls (Sham: 73.63 ± 6.11 pg/µg 
protein vs. P. aeruginosa + IgG Control: 103.51 ± 8.83pg/µg protein, P<0.05, Figure 2A). β-
TG levels also appeared to be elevated in BAL fluid obtained 24 hours post infection (Sham: 
2.12 ±0.15 pg/µg protein vs. P. aeruginosa + IgG Control: 3.38 ± 0.71 pg/µg protein), 
although this increase did not reach statistical significance (Figure 2B). 
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No detectable changes in plasma PF-4 levels were observed 24 hours post infection (Figure 
2C). However, at this timepoint PF-4 levels were significantly elevated in the BAL fluid 
suggesting that PF-4 may only be released by platelets at the site of infection (Sham: 0.18 ± 
0.01 OD vs. P. aeruginosa: 0.31 ± 0.05 OD, P < 0.05 Figure 2D). 
 
Histological evidence for platelet accumulation in lung tissue following P. aeruginosa 
infection 
Lung samples collected 24 hours post infection, stained with an anti-neutrophil elastase 
antibody or with a H&E stain, indicated an increase in neutrophil recruitment into the 
airway lumen and alveolar spaces (Figure 3A). In these samples, an increase in platelet 
specific staining was also observed through specific anti-CD42b staining (Figure 3B). This 
staining was quantified and a significant increase in extravascular pulmonary platelet 
accumulation was observed in mice infected with P. aeruginosa compared to sham control 
mice (Sham: 3568.33 ± 457.53 platelets/mm
2
 vs. P. aeruginosa: 9670 ± 1457.06 
platelets/mm
2
, P<0.01, Figure 3C). Regions positive for CD42b also appeared to be present 
around bacteria in the airways of P. aeruginosa infected mice (data not shown). However, 
further research is required to identify whether this is representative of direct platelet-
bacterial interactions that have previously been observed in vitro [17]. Platelet recruitment 
into the airway lumen was subsequently confirmed using platelet specific anti-CD41 staining 
on slides prepared from isolated BALF, which when quantified demonstrated significant 
increases in platelets present in the lavage fluid of infected mice (Sham: 0.30 ± 0.16x10
3
 
platelets/ml vs. P. aeruginosa: 2.64 ± 0.58x10
3
 platelets/ml, P<0.01, Figure 3D). 
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Experimentally induced platelet depletion significantly decreased P. aeruginosa induced 
pulmonary leukocyte recruitment 
To understand whether the pulmonary accumulation of platelets in response to P. 
aeruginosa infection was a cause or consequence of the immune response to the invading 
pathogen, we conducted experiments in which mice were experimentally depleted of 
circulating platelets. To induce a sufficient decrease in circulating platelet numbers (> 80%), 
mice were treated with either an IgG control antibody or 10µM of the polyclonal anti-GPIbα 
platelet depleting antibody prior to infection with P. aeruginosa. This induced a significant 
state of platelet depletion in both studies (85%, P<0.001, Figure 1A & B) which was 
maintained throughout the 24-hour study period.  No effects of the anti-GP1bα platelet 
depleting antibody were observed on whole blood neutrophil counts (Supplementary 
Figure 1B). 
Infection with 1x10
6
 cfu/mouse P. aeruginosa induced a significant increase in total 
pulmonary leukocyte recruitment (P<0.05) at 24 hours (Figure 4A). This was characterised 
by a significant increase in pulmonary neutrophil recruitment (P<0.01) (Figure 4B) as well as 
increases in both lymphocytes and macrophages, although these latter cell types did not 
achieve statistical significance (Figure 4C+D). Mice depleted of circulating platelets (>85%) 
demonstrated a reduction in P. aeruginosa induced total leukocyte recruitment, although 
this was not significant (Figure 4A). However, a significant reduction in neutrophil 
recruitment was observed (P<0.05) (Figure 4B) as well as a reduction in lymphocyte 
numbers, although this was not significant (Figure 4C). No discernible changes in pulmonary 
macrophage numbers were observed in mice depleted of circulating platelets (Figure 4D).  
Similarly, in mice inoculated with 1x10
5
 cfu/mouse P. aeruginosa, total pulmonary leukocyte 
recruitment was significantly elevated (P<0.001), which was also characterised by a 
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significant increase in neutrophil recruitment (P<0.001). In mice depleted of circulating 
platelets both total pulmonary leukocyte recruitment (P<0.01) whilst both neutrophil 
(P<0.05) and macrophage (P<0.05) recruitment were significantly reduced (Supplementary 
Figure 2). 
 
Bacterial colonisation is enhanced significantly in mice depleted of platelets. 
24 hours post infection, mice inoculated with sterile PBS embedded agar beads 
demonstrated no evidence of infection in the lungs, kidney or spleen. In contrast, mice 
infected with 1x10
6
 cfu/mouse and treated with an IgG control antibody demonstrated a 
significant increase in total pulmonary bacterial load (5.08 ± 0.54 log cfu/ml, P<0.001, Figure 
5A), with minimal systemic infection observed in the kidneys and spleen (Figure 5B+C). 
However, in mice depleted of circulating platelets, pulmonary bacterial load was 
significantly increased compared to IgG control treated mice (6.62 ± 0.35 log cfu/ml, 
P<0.05). This was described by an increase in pulmonary bacterial load of approximately 1.5 
log cfu increase (Figure 5A). This increase was accompanied by an additional increase in 
bacterial numbers in both the kidney and spleen in mice depleted of platelets, although this 
did not reach statistical significance (Figure 5B+C). To investigate further the increase in the 
incidence of systemic infection, we performed further experiments to measure bacterial 
load 24 hours post infection using a lower inoculum of 1x10
5
 cfu/mouse P. aeruginosa. The 
primary objective of using a lower inoculum was to reduce the severity of the model as we 
had seen an increase in the incidence of mortality following infection with 1x10
6
 cfu/mouse. 
In animals infected with the lower inoculum of 1x10
5
 cfu/mouse P. aeruginosa, no infection 
was observed in the lungs, spleen of kidneys of mice inoculated with sterile agar beads 
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(Figure 5D-F and Supplementary Figure 3A-C). Mice treated with the IgG control antibody 
and infected with the lower inoculum of 1x10
5
 cfu/mouse P. aeruginosa also showed a 
significant elevation in total pulmonary bacterial load (4.72 ± 0.39 log cfu/ml, P < 0.001, 
Figure 5D). In contrast to the data collected from mice infected with 1x10
6
 cfu/mouse, mice 
depleted of platelets prior to infection with 1x10
5
 cfu/mouse P. aeruginosa did not show a 
significant increase in total bacterial load 24 hours post infection compared to IgG control 
antibody treated mice (5.21 ± 0.39 log cfu/ml). However, a small non-significant increase of 
0.5 log cfu was observed in the lung. This could be explained by the lower inoculum 
producing a less severe infection within the lungs compared to the 1x10
6
 cfu/mouse 
inoculum. Similarly, to the studies using 1x10
6
 cfu/mouse, IgG control antibody treated 
infected mice demonstrated no systemic infection in the spleen and kidneys. In contrast, in 
mice depleted of platelets, we demonstrated a significant elevation in bacterial numbers in 
the kidney (log 2.07 ± 0.24 cfu/ml, P < 0.001, Figure 5E) and the spleen (log 0.74 ± 0.36 
cfu/ml, P < 0.05, Figure 5F). 
 
Mice depleted of platelets infected with P. aeruginosa demonstrated increased mortality 
In mice infected with 1x10
6
 cfu/mouse P. aeruginosa we observed a significantly increased 
mortality rate (40%, P<0.05) in mice experimentally depleted of platelets compared with IgG 
control antibody treated mice (0%) (Figure 6A). Following infection with 1x10
5
 cfu/mouse, 
mice depleted of circulating platelets showed a decreased mortality rate compared to those 
infected with 1x10
6
 cfu/mouse P. aeruginosa with mortality levels of only 20%. However, 
this was still elevated when compared to mice infected with 1x10
5
 cfu/mouse which had 
received the IgG control antibody (0%) (Figure 6B). These data suggest that whilst the 
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infection profile with the lower inoculum was associated with decreased severity with no 
significant difference observed, the experimental depletion of circulating platelets 
continued toproduce a trend suggesting a more severe phenotype. As increases in mortality 
were observed, we investigated the potential cause of death in these animals. Metabolic 
acidosis is a known biomarker of organ dysfunction in septic patients, and severe metabolic 
acidosis is indicative of multiple organ dysfunction syndrome (MODS)[23]. We therefore 
assessed blood biochemical markers associated with metabolic acidosis in animals following 
infection with 1x10
5
 cfu/mouse P. aeruginosa. In the mice that survived the 24-hour study 
duration, no significant differences were observed in blood Urea, pH, Base Excess HCO3, 
pCO2 levels and the Anion Gap. However, a trend towards a decrease in these parameters 
was observed in infected mice depleted of circulating platelets (Supplementary Table 1). 
Whilst these data did not show any significant differences, the subtle changes observed are 
consistent with metabolic acidosis and the absolute values and degree of the changes are 
consistent with previously published models of systemic inflammatory response syndrome 
(SIRS) and septic infection [24]. The shift in the systemic blood biochemistry observed in 
these animals may have been more pronounced in the animals that died prior to the 24-
hour end point of the study, therefore further work is required to identify if metabolic 
acidosis leading to MODS is the primary cause of death in these animals. 
 
Platelets Modulate Bacterial Growth kinetics in vitro 
Our in vivo studies detected an increase in total bacterial load 24 hours post infection. 
Animals infected with the higher inoculum demonstrated a 1.5 log cfu increase in 
pulmonary bacterial load (5.08 ± 0.54 vs 6.62 ± 0.35 log cfu). This was interesting as this 
Page 14 of 50 AJRCMB Articles in Press. Published on 28-September-2017 as 10.1165/rcmb.2017-0083OC 
 Copyright © 2017 by the American Thoracic Society 
 14 
 
strain of P. aeruginosa has previously demonstrated a similar log cfu increase over the same 
time period in in vitro cultures [25]. We therefore investigated whether platelets had any 
effect on bacterial growth in vitro. Platelet bacteria co-culture experiments were performed 
and cfu’s quantified over an 8-hour time course. Bacteria cultured in the presence of 
1x10
6
/ml platelets demonstrated significant decreases at both 6 (Bacteria alone: log 8.49 ± 
0.22 cfu/ml vs. Bacteria + Platelets: log 7.74 ± 0.42 cfu/ml, P < 0.05) and 8 hours (Bacteria 
alone: log 8.91 ± 0.19 cfu/ml vs. Bacteria + Platelets: log 7.80 ± 0.28 cfu/ml, P < 0.001) when 
compared to bacterial cultures in the absence of platelets (Figure 7). 
 
DISCUSSION 
Here we provide compelling evidence that platelets play an important role in the host 
response to pulmonary bacterial infection with P. aeruginosa. In our model, we have 
demonstrated that experimentally induced platelet depletion permits increased pulmonary 
bacterial growth and systemic bacterial dissemination, which is not normally associated with 
infections with this strain of P. aeruginosa. Our observations therefore support the 
hypothesis that platelets play a significant role in containing bacterial infections to the lung. 
Furthermore, we also provide evidence that platelets are required for neutrophil 
recruitment to the lung in an analogous manner to that described in other animal models of 
pulmonary leukocyte recruitment following both allergic and non-allergic inflammatory 
insults [6,7, 9]. 
Platelets (Murine and Human) variably express Toll-like Receptors (TLR) 2 and 4 on their 
surface [26]. TLR2 and TLR4 receptors recognise bacterial peptidoglycans and 
lipopolysaccharides (LPS) in gram-positive and gram-negative pathogens respectively [27–
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30]. This provides a plausible mechanism for direct bacterial interactions with platelets 
which may contribute towards platelet activation. Indeed, platelet shape change, reversible 
states of platelet accumulation and adhesion, formation of platelet-leukocyte conjugates, 
elevated P-selectin expression and platelet granule release have all been detected following 
exposure to bacterial products or through direct interactions with bacterial pathogens, 
including S.aureus, Streptococcus pyogenes, Escherichia Coli and Clostidium perfringens 
[18,31,32]. 
Here we demonstrate that infection with 1x10
6
 cfu/mouse of P. aeruginosa resulted in 
increased BAL levels of platelet derived PF-4 and β-TG at 24 hours post infection. This 
supports bacterial induced platelet activation previously described in the literature [14–
16,18,31,32]. We also observed significant increases in plasma β-TG levels, although no 
increases in plasma PF-4 were detected. This may suggest that PF-4 is only released at the 
site of infection. Furthermore, we have demonstrated platelet accumulation in the lung, in 
agreement with published literature demonstrating pulmonary platelet accumulation 
following exposure to bacterial products [33], coupled with that observed in response to 
both allergic and sterile inflammatory stimuli [9,34].  
Our group has previously demonstrated an important role for platelets in leukocyte 
recruitment induced by both allergic and non-allergic inflammatory insults [5,6,8]. In the 
present study, we have extended these observations by showing an important role for 
platelets in pulmonary neutrophil recruitment following a bacterial infection, where we 
observed a significant decrease in neutrophil recruitment into the lungs in mice depleted of 
circulating platelets by greater than 85%. In our previous studies, using different 
inflammatory models we reported a more profound effect on pulmonary leukocyte 
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recruitment, this is perhaps due to the increased levels of platelet depletion (>95%), or to 
differences in the severity of the inflammatory response [5,6,8]. We have also recently 
demonstrated that pulmonary leukocyte recruitment following allergen challenge was P2Y1 
dependent [8]. This observation is of interest as P2Y1 and P2Y2 receptors have been 
postulated to exert a protective role against infection with P. aeruginosa from observations 
of increased mortality and decreased pro-inflammatory cytokine release in P2Y1, P2Y2 single 
and double knockout mice [35].  It is therefore plausible that platelet P2Y1 receptor 
activation may be involved in pulmonary neutrophil recruitment in this lung infection 
model, similarly to that described for pulmonary cell recruitment either following allergen 
challenge or through exposure to LPS [8,36]  
In addition to the engulfment of bacteria by neutrophils and the subsequent degradation of 
the pathogen through both oxidative and non-oxidative mechanisms, Neutrophil 
extracellular traps (NETs) are another mechanism which neutrophils can contribute to the 
killing and removal of bacteria from infected tissue [37–39]. The decreased pulmonary 
recruitment observed in our study in mice depleted of platelets is likely to contribute to the 
more severe phenotype observed as this will result in decreased capacity for neutrophil 
mediated bacterial trapping and killing [38,39]. However, our study only shows a partial 
inhibition of neutrophil recruitment, therefore there appears to be a component of 
neutrophil influx that is platelet independent following bacterial infection in the lung. 
Several studies have highlighted that platelets can induce NETosis through activation of 
neutrophils, either via direct interactions, release of mitochondria or via mitochondria 
containing platelet microparticles [37,40]. Clark and colleagues demonstrated that LPS 
stimulation, even at high concentrations, was insufficient to induce NETosis directly from 
neutrophils, and that platelet induced neutrophil activation is required for rapid LPS-
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induced NETosis [28]. Whether this provides an additional mechanism by which platelets 
may be involved in the trapping and killing of bacteria in septic blood remains unclear and 
requires further study. 
In the present study, pulmonary bacterial load in animals infected with 1x10
6 
cfu/mouse P. 
aeruginosa increased by 1.5 log cfu’s over 24 hours in mice depleted of circulating platelets 
when compared to non-thrombocytopenic mice, whilst a more moderate 0.5 log cfu 
increase was observed following infection with the lower 1x10
5
 cfu/mouse inoculum. The 
significant decrease in neutrophil recruitment in platelet depleted mice is one mechanism 
by which to explain this increase in pulmonary bacterial load as neutrophils are essential in 
host defence towards bacterial infections through pathogen elimination. This has been 
shown through the susceptibility of neutropenic mice to this pathogen. However, it is 
interesting to note that the increased growth of bacteria (~1.5 log cfu/24 hours) in our 
model is similar to that observed for this strain in isolated in vitro cultures [25], suggesting 
that the platelets may contribute an additional component to the mechanisms restricting 
bacterial growth and survival in vivo further to neutrophil associated mechanisms. To this 
end, we performed bacterial growth curves both in the presence and absence of platelets to 
assess their role independent of neutrophils and demonstrated a significant reduction in 
viable bacteria at both 6 and 8 hours when cultured in the presence of platelets. This may 
indicate a mechanism that in vitro, may enable platelets to modulate bacterial growth 
kinetics independent of neutrophils, in addition to normal neutrophil involvement. The 
possibility of a direct mechanism of platelet modulation on bacterial growth is supported by 
work performed by Kramer and colleagues who demonstrated that the presence of platelets 
decreased the growth of S. aureus in vitro [41], and by the studies of De Stoppelaar et al 
who have demonstrated an increased bacterial burden in P-selectin deficient mice [16]. The 
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mechanism by which platelets limit bacterial growth is unclear, although work published 
from other laboratories has suggested that platelets have the capacity to directly internalise 
and phagocytose pathogens [14,42]. Whilst our in vitro findings highlight the possibility for a 
mechanism for platelet specific modulation of bacterial growth kinetics, the mechanisms 
behind this are beyond the scope of this study and further work is required to evaluate the 
mechanisms involved, and to what extent this is involved in in vivo models of infection. 
The model of lung infection used in our study was adapted from a well-documented model 
of pulmonary infection with P. aeruginosa originally described by Cash and colleagues in 
1979. This model has since been replicated by a number of independent research 
laboratories to investigate pulmonary infection in a number of species and is considered to 
be a non-systemic and non-fatal lung infection model [43]. However, in our studies 
following an inoculum of 1x10
6
 cfu/mouse P. aeruginosa, we observed a trend depicting an 
increase in the presence of systemic infection in the kidneys and spleen, and increased 
mortality (40%) in thrombocytopenic mice. When this study was repeated using a lower 
(1x10
5
 cfu/mouse) inoculum to refine the model and decrease the severity we saw no 
evidence of systemic bacterial dissemination to the kidneys or spleen in mice with normal 
platelet levels. However, in mice experimentally depleted of circulating platelets we 
observed a significant increase in systemic bacterial numbers recovered from both the 
kidneys and the spleen. Whilst the mortality rates were lower than with the higher 1x10
6
 
cfu/mouse inoculum, we still observed subtle increases in mortality (20%) in platelet 
depleted animals following infection with the lower 1x10
5
 cfu/mouse inoculum.  Our 
observations suggested a conversion from a phenotype associated with localised infection 
to one displaying systemic infection as we demonstrated increased bacterial load in 
systemic organs, a subtle increase in biochemical markers of metabolic acidosis and 
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increased mortality. This suggests that platelets may play an important role in maintaining 
the integrity of the pulmonary vasculature to normally restrict pulmonary infections to the 
lung and preventing systemic bacterial dissemination towards distal organs. Indeed, others 
have shown that high circulating platelet numbers (5-13x10
9
 platelets/litre) can prevent 
bleeding and offer protection against distal organ damage during gram-negative sepsis [15], 
whilst mice with platelets with impaired function through genetic deficiency of P-selectin 
demonstrate increased organ damage following K. pneumoniae infection [16]. We therefore 
suggest that in addition to normal neutrophil roles in bacterial infections, the removal of 
platelet mediated trapping and killing of bacteria through interactions with neutrophils, or 
through additional direct interactions with bacteria allows a transition from a mild to more 
severe infectious phenotype, supporting observations that worse clinical outcomes are 
associated with thrombocytopenia in patients with infections [11–13]. 
In conclusion, we have demonstrated that P. aeruginosa infection induces significant 
platelet activation and accumulation in lung tissue and BAL fluid 24 hours post infection. 
Furthermore, mice depleted of platelets demonstrated a 1.5 log cfu increase in pulmonary 
bacterial load, coupled with a similar increase in systemic bacterial load. Additionally, we 
observed a significant decrease in neutrophil recruitment following platelet depletion, 
which was associated with increased weight loss (Supplementary figure 4) and reduced 
survival rates from a strain of bacteria that is normally sub-lethal. We therefore conclude 
that in addition to the role that neutrophils play in the host response to bacterial infections, 
platelets also have distinct role in host defence against gram-negative infections in the lung. 
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Figure Legends 
Figure 1. Pulmonary P. aeruginosa infection is associated with mild systemic 
thrombocytopenia. Mice were treated with either 10µM anti-GPIbα platelet depleting 
antibody (open circles) or IgG control antibody (filled circles) and infected with sterile PBS 
embedded agar beads and either 1x10
6
 (A) or 1x10
5
 (B) cfu/mouse P. aeruginosa embedded 
agar beads through intra-tracheal inoculation. 24 hours post infection, circulating platelet 
counts were enumerated from whole blood using a Zeiss axioscope microscope under a x40 
objective. N=5-10. Data are expressed as mean ± SEM, * =p<0.05 compared to sham control 
mice, ### = P< 0.001 compared to P.aeruginosa + IgG control treated mice. Data was 
confirmed for Guassian distribution using the Shapira-Wilks normality test and subsequently 
analysed using one-way ANOVA and the Bonferroni multiple comparisons post test. 
 
Figure 2. P. aeruginosa infection is associated with increased release of the platelet 
derived mediators β-TG and PF-4. Mice were infected with sterile PBS embedded agar 
beads and 1x10
6
 cfu/mouse P. aeruginosa embedded agar beads through intra-tracheal 
inoculation. 24 hours post infection, plasma & BAL fluid were collected. ELISAs were 
performed on plasma and BAL fluid for quantification of the platelet derived mediators β-TG 
(A, B) and PF-4 (C,D). n = 4-7. Data are expressed as mean ± SEM mice, * = P< 0.05 
compared to sham control mice. Data was confirmed for Guassian distribution using the 
Shapira-Wilks normality test and subsequently analysed using one-way ANOVA and the 
Bonferroni multiple comparisons post test. 
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Figure 3. P. aeruginosa infection is associated with increased pulmonary leukocyte 
recruitment and pulmonary platelet accumulation in vivo. Mice were infected with sterile 
PBS embedded agar beads and 1x10
6
 cfu/mouse P. aeruginosa embedded agar beads 
through intra-tracheal inoculation. 24 hours’ post infection, lungs were removed and fixed 
in 10% PFA. Tissue sections were stained with neutrophils (neutrophil elastase), H&E and 
platelets (anti CD42b). A: Representative sections at x40 magnification of both parachemya 
from sham and 1x10
6
 cfu/mouse P. aeruginosa infected mice for Neutrophil Elastase (i-ii) 
and H&E staining (iii-iv). B: Representative sections at x63 magnification of CD42b positive 
staining from sham (i-ii) and 1x10
6
 cfu/mouse P. aeruginosa (iii-iv) with red arrows 
indicating extravascular positive events. C: Quantification of CD42b positive staining in the 
tissue for analysis of platelet diapedesis. D: Quantification of platelet staining (CD41a) in BAL 
fluid from cytospin slides. n = 5-8 Data are expressed as mean ± SEM ** = P< 0.01 compared 
sham control mice. Data was confirmed for Guassian distribution using the Shapira-Wilks 
normality test and subsequently analysed using one-way ANOVA and the Bonferroni 
multiple comparisons post test. 
Figure 4. P. aeruginosa induced pulmonary leukocyte recruitment is reduced in platelet 
depleted mice. Mice were treated with either 10µM anti-GPIbα platelet depleting antibody 
(open circles) or IgG control antibody (filled circles) and infected with sterile PBS embedded 
agar beads and 1x10
6
 cfu/mouse P. aeruginosa embedded agar beads through intra-tracheal 
inoculation. 24 hours post infection, BAL fluid was obtained and analysed for total cell 
counts (A), Neutrophils (B), Lymphocytes (C) and Macrophages (D). n=5-8. Data are 
expressed as mean ± SEM. * = P< 0.05, ** = P< 0.01 compared to sham control mice, # = P< 
0.05 compared to IgG control infected P. aeruginosa mice. Data was confirmed for Guassian 
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distribution using the Shapira-Wilks normality test and subsequently analysed using one-
way ANOVA and the Bonferroni multiple comparisons post test. 
Figure 5. Depletion of circulating platelets is associated with increased pulmonary load 
and systemic dissemination of bacteria following infection with P. aeruginosa. Mice were 
treated with either 10µM anti-GPIbα platelet depleting antibody (open circles) or IgG 
control antibody (filled circles) and infected with sterile PBS embedded agar beads and 
1x10
6
 cfu/mouse (A-C) or 1x10
5
 cfu/mouse (D-F) P. aeruginosa embedded agar beads 
through intra-tracheal inoculation. 24 hours post infection, the number of colony forming 
units (cfus) in Lung (A & D), Kidney (B & E) and Spleen homogenates (C & F) were quantified 
on TSA plates. n=5-10. Data expressed as Log mean ± SEM. * = P< 0.05, *** = P< 0.001 
compared to sham control mice, # = P< 0.05, ### = P< 0.001 compared to IgG control 
infected P. aeruginosa  mice, LOD = Limit of Detection. Data was confirmed for Guassian 
distribution using the Shapira-Wilks normality test and subsequently analysed using one-
way ANOVA and the Bonferroni multiple comparisons post test. 
 
Figure 6. Depletion of circulating platelets is associated with increased mortality. Mice 
were treated with either 10µM anti-GPIbα platelet depleting antibody (blue triangle) or IgG 
control antibody (red square). Survival numbers were collected following infection with 
sterile PBS embedded agar beads and either 1x10
6
 (A) or 1x10
5
 (B) cfu/mouse P. aeruginosa 
embedded agar beads through intra-tracheal inoculation. n = 6-15. Survival plotted as 
survived = 0, dead = 1. * = P< 0.05 compared to IgG control treated P. aeruginosa infected 
mice.  
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Figure 7. Platelets reduce total bacterial numbers in culture in vitro. In vitro cultures of 
1x10
6
 cfu/ml P. aeruginosa were prepared alone (filled circle) or in the presence of 1x10
6
 
platelets/ml (filled square). Aliquots were taken at 0, 2, 4, 6 and 8 hours and viable colony 
forming units quantified on TSA plates. n= 6. Data expressed as Log mean ± SEM. * = P< 
0.05, *** = P< 0.001 compared to bacterial control cultures. Data was confirmed for 
Guassian distribution using the Shapira-Wilks normality test and subsequently analysed 
using one-way ANOVA and the Bonferroni multiple comparisons post test. 
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SUPPLEMENTAL METHODS 
Materials 
P. aeruginosa strain RP73 was obtained from a CF patient attending the Medizinische 
Hochschule of Hannover, Germany [20]. C57/Bl6 (8-10 weeks) male mice were obtained 
from Charles River, Italy or Harlan, UK. Other reagents were obtained from commercial 
suppliers: Tryptic Soy Agar (TSA), Trypticase Soy Broth, polyclonal anti-GPIbα platelet 
depleting antibody and IgG control antibody, platelet specific anti-CD41 antibody, anti-
CD42b antibody, PF-4 ELISA and a β-TG ELISA, secondary mouse-absorbed biotinylated anti-
rat secondary antibody.  
 
Preparation of agar beads embedded with P. aeruginosa 
Using the method described by Bragonzi and colleagues [21], an overnight culture of P.  
aeruginosa strain RP73 was prepared in tryptic soy broth (TSB). This strain was chosen due 
to its lower acute virulence when compared to other P. aeruginosa strains, such as PAO1 
[20], therefore reducing the expected severity of the lung infection following inoculation. P. 
aeruginosa strain RP73 was cultured in TSB overnight at 37°C, adjusted to a starting OD600nm 
of 0.025, and grown for additional 4 h for agar beads preparation. Bacteria were embedded 
into agar beads by mixing the overnight culture with molten tryptic soy agar, which was 
then spun into warmed mineral oil. The preparation was cooled and centrifuged at 2,700 g, 
the remaining oil was eliminated and the beads were washed in sterile PBS. The colony 
forming unit (cfu) content of the beads slurry was subsequently quantified on TSA plates 
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and the beads slurry then diluted to either 2x10
7
 cfu/ml or 2x10
6
 cfu/ml in sterile PBS to 
deliver a final dose of either 1x10
6
 or 1x10
5
 cfu/mouse. 
 
Infection with P. aeruginosa and induction of platelet depletion in mice 
Animal work was conducted according to protocols approved by San Raffaele Scientific 
Institute (Milan, Italy) Institutional Animal Care and Use Committee (IACUC) and adhered 
strictly to the Italian Ministry of Health guidelines for the use and care of experimental 
animals. For studies using the 1x10
6
 cfu/mouse inoculum on day 0, male C57Bl6 mice were 
temporarily anesthetized by intraperitoneal injection (i.p.) of 2.5 mg of 2,2,2-tribromethanol 
(Avertin, Sigma) in 0.9% NaCl and administered in a volume of 15 µl/g of body weight. The 
trachea was cannulated and a 50µl inoculum of bacteria embedded in agar beads (10
6
 
cfu/mouse) was instilled directly into the respiratory tract. The trachea was cannulated with 
a sterile flexible 22-gauge catheter (Becton Dickinson, Madrid, Spain). Sham control mice 
were inoculated with sterile PBS agar beads. Body weight was measured daily and animals 
monitored at regular intervals for signs of pain and distress. 
Additional studies using an inoculum of 1x10
5
 cfu/mouse were performed in accordance 
with the Animals (Scientific Procedures) Act of 1986 (United Kingdom). On day 0, male 
C57Bl6J mice were anesthetized under Isoflurane and 50µl inoculum of bacteria embedded 
in agar beads (10
5
 cfu/mouse) was instilled directly into the respiratory tract via 
oropharyngeal dosing (o.a) to reduce severity associated with surgery. Sham control mice 
were inoculated with sterile PBS agar beads. Body weight was measured daily and animals 
monitored at regular intervals for signs of pain and distress.  
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24 hours prior to infection, mice were treated intra-muscularly (i.m) with either 10µM of the 
polyclonal anti-GPIbα platelet depleting antibody (#R300, Emfret Analytics) or an IgG control 
antibody. Circulating platelet numbers were enumerated from whole blood collected via tail 
clips in stromatol on an improved Neubauer haemocytometer 24 hours post infection to 
ensure sufficient platelet depletion (>80% depletion). 
 
Lung, spleen and kidney harvest for microbiological and histological analysis  
24 hours post infection, animals were terminally euthanized with a mix to O2 50%/CO2 50% 
or 25% Urethane. Lungs, kidneys and spleens were removed and homogenized in 2ml PBS. 
Samples were serially diluted 1:10 in PBS and plated for CFU count. Lung, kidney and spleen 
homogenates were then centrifuged at 14000 rpm for 30 min at 4°C and the supernatants 
were stored at -80°C for cytokine analysis.  
For additional mice, lungs were inflated with 10% (v/v) buffered formalin and immersion 
fixed for 48 hours. Post fixation, lungs were sliced horizontally and processed into paraffin 
embedded blocks. De-waxed slices (5µm thick) prepared on a microtone were subsequently 
stained with a routine haematoxylin and eosin stain or for neutrophil elastase to permit 
histological assessment. Additional slides were stained for platelets using a platelet specific 
anti-CD42b antibody (#ab183345, abcam), a secondary mouse-adsorbed biotinylated anti-rat 
rabbit secondary antibody (Vector, BA-1000, 1:200), and an ABC Vectastain kit to assess 
platelet recruitment into different anatomical regions of the lung. 
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Bronchoalveolar lavage fluid collection and analysis (total and differential cell count) 
A 22-gauge catheter was inserted into the trachea and BAL was recovered by instillation of 1 
ml of RPMI 1640 three times and total cells counts were performed by adding Turks stain in 
a 1:1 ratio. Total cells were then enumerated on an improved Naubauer haemocytometer. 
BAL fluid were then centrifuged and supernatants were collected for quantification of total 
protein content.  
Cytospin slides were prepared and 150ul of BAL was added into a cytospin funnel and 
centrifuged at 960rpm for 5 minute on a medium acceleration. The slides were then stained 
using Diff-Quick (Dade, Biomap, Italy). In addition, whole blood was diluted 1/100 in 
stromatol stain and circulating platelet numbers were quantified using an improved 
Neubauer haemocytometer under an x40 objective. 
 
Platelet quantification in BAL fluid 
The collected BALF was mixed and an aliquot removed and added into a cytospin funnel and 
centrifuged at 1000rpm for 1 minute on a slow acceleration. The slides were then stained 
with a primary anti-CD41 antibody (#SC-6604, Santa Cruz) and a secondary mouse-absorbed 
biotinylated anti-rat secondary antibody. Using an avidin-biotin-HRP complex, platelets in 
the BALF were quantified. 
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Quantification of the release of the platelet activation markers PF-4 and β-TG via ELISA 
24 hours post infection, serum was isolated from citrated whole blood and BAL fluid. Total 
levels of platelet released PF-4 and β-TG were quantified from all samples and were 
measured by ELISA according to the manufacturer (R&D systems). 
 
Evaluation of biochemical markers of metabolic acidosis 
24 hours post infection with 1x10
5
 cfu/mouse P. aeruginosa, blood was collected via cardiac 
puncture into heparin coated syringes. 65µl blood was transferred to EC8+ blood analyser 
cartridges (Point of Care Testing ltd: AB-3P7925) and processed using a handheld i-STAT 
blood analyser to quantify a panel of biochemical markers including pH, Urea, Base Excess, 
Bicarbonate ions, pCO2 and Anion Gaps. 
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Supplementary Legends 
Supplementary Figure 1. anti-GPIbα antibody depletes circulating platelet in sham 
infected mice. Mice were treated with either 10µM anti-GPIbα platelet depleting antibody 
(open symbols) or IgG control antibody (filled symbols) and infected with either sterile PBS 
embedded agar beads (squares) or 1x10
5 
cfu/mouse P. aeruginosa (circles) through intra-
tracheal inoculation.  24 hours post infection, circulating platelet count (A) and whole blood 
neutrophil counts (B) were enumerated from whole blood using a Zeiss axioscope 
microscope under a x40 objective. N=8. Data are expressed as mean ± SEM, *** =p<0.001 
compared to sham IgG treated control mice. Data was confirmed for Guassian distribution 
using the Shapira-Wilks normality test and subsequently analysed using one-way ANOVA 
and the Bonferroni multiple comparisons post test. 
 
Supplementary Figure 2. P. aeruginosa induced pulmonary leukocyte recruitment is 
reduced in platelet depleted mice. Mice were treated with either 10µM anti-GPIbα platelet 
depleting antibody (open circles) or IgG control antibody (filled circles) and infected with 
sterile PBS embedded agar beads and 1x10
5
 cfu/mouse P. aeruginosa embedded agar beads 
through intra-tracheal inoculation. 24 hours post infection, BAL fluid was obtained and 
analysed for total cell counts (A), Neutrophils (B) and Macrophages (C). n = 4-6. Data are 
expressed as mean ± SEM. *** = P< 0.001 compared to sham control mice, # = P< 0.05, ## = 
P < 0.01 compared to IgG control infected P. aeruginosa mice. Data was confirmed for 
Guassian distribution using the Shapira-Wilks normality test and subsequently analysed 
using one-way ANOVA and the Bonferroni multiple comparisons post test. 
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Supplementary Figure 3. Effects of platelet depletion on bacterial numbers in sham 
infected mice. Mice were treated with either 10µM anti-GPIbα platelet depleting antibody 
(open squares) or IgG control antibody (filled squares) and infected with sterile PBS 
embedded agar beads through intra-tracheal inoculation. 24 hours post infection, the 
number of colony forming units (cfus) in Lung (A), Kidney (B) and Spleen homogenates (C) 
were quantified on TSA plates. n=8-10. Data expressed as Log mean ± SEM, LOD = Limit of 
Detection.  
 
Supplementary Figure 4. Pulmonary P. aeruginosa infection is associated with increased 
weight loss. Mice were treated with either 10µM anti-GPIbα platelet depleting antibody 
(open circles) or IgG control antibody (filled circles) and infected with sterile PBS embedded 
agar beads and either 1x10
6
 (A) or 1x10
5
 (B) cfu/mouse P. aeruginosa embedded agar beads 
through intra-tracheal inoculation. Mice were weighed daily for the duration of the study 
and weight loss over time calculated, n= 4-10. Data expressed as mean ± SEM. ** = P< 0.01 
compared to sham control mice. Data was analysed using the Kruskal-Wallis test of variance 
followed by the Bonferonni multiple comparison post-test. 
 
Supplementary Table 1. Depletion of circulating platelets in infected mice is associated 
with biochemical markers of metabolic acidosis. Mice were treated with either 10µM anti-
GPIbα platelet depleting antibody or IgG control antibody and infected with sterile PBS 
embedded agar beads or 1x10
5
 cfu/mouse P. aeruginosa embedded agar beads through 
intra-tracheal inoculation. 24 hours post infection, blood was collected via cardiac puncture 
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and blood biochemical markers were measured using EC8
+
 blood analyser cartridges on an i-
STAT handheld blood analyser, n = 4-6. Data expressed as mean ± SEM. 
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Supplementary Figure 1
A B
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A B C
Supplementary Figure 2
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Supplementary Figure 3
A B C
Page 48 of 50 AJRCMB Articles in Press. Published on 28-September-2017 as 10.1165/rcmb.2017-0083OC 
 Copyright © 2017 by the American Thoracic Society 
Supplementary Figure 4
A B
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